The Latest Breaking News from FDA

Artificial zero-calorie sweeteners are commonly used in processed and keto-friendly foods.

An infection that's usually easy to treat with common antibiotic eyedrops "has become an infection that can be deadly and has pretty much no treatment except one IV antibiotic,” one expert said.

The FDA will decide whether to approve a neurological disease drug from Reata Pharmaceuticals this week, but RETA stock plummeted Monday.

Pfizer (PFE) reported record-breaking revenue and earnings for fiscal 2022. Furthermore, the combination of expected launches and additional pipeline products position the company for continued robust growth through the rest of this decade and beyond. Amid a volatile macro environment, investing in this high-value stock for the long term could…

You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old.

‘Innocent until proven guilty’, says deputy PM on investigation into allegations

A coalition of state attorneys general is suing the Food and Drug Administration over its regulation of mifepristone. NPR's Michel Martin speaks with Washington state Attorney General Bob Ferguson.

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine.

The at-home nasal swab kit simultaneously tests for COVID-19 and two strains of the flu.